| Peggy Pinkston |
Peggy Pinkston is currently the Chief Human Resources Officer at Seagen Inc. Previously, she worked as the Director-Investor Relations at aQuantive, Inc. She completed her undergraduate degree at Washington State University. |
| Natasha A. Hernday |
Natasha A. Hernday is an Independent Director at XOMA Corp. and Alpine Immune Sciences, Inc. She is also the Chief Business Officer at Seagen Inc. Previously, she worked as the Director-Mergers, Acquisitions & Out-Partnering at Amgen, Inc. from 1994 to 2010 and as an Independent Director at PDL BioPharma, Inc. from 2019 to 2022. Ms. Hernday holds an MBA from Pepperdine University and an undergraduate degree from the University of California, Santa Barbara. |
| William Compton |
William Compton is currently the Director at Tech Impact and the SVP-Global Information Technology at Seagen Inc. He previously worked as the Chief Information Officer & Senior Vice President at Integra LifeSciences Holdings Corp. from 2013 to 2023 and as the Chief Information Officer & Vice President at Convatec Group Plc from 2008 to 2012. Mr. Compton holds an MBA from The College of William & Mary and completed his undergraduate and graduate studies at East Carolina University. |
| Karin A. Tollefson |
Karin A. Tollefson is currently the Director at the American Lung Association in Arizona, Independent Director at Verastem, Inc., Senior VP & Head-Global Medical Affairs at Seagen Inc., and Trustee at The Leukemia & Lymphoma Society, Inc. Previously, she worked as the Director at the American Lung Association. She completed her undergraduate degree at Kansas State University and obtained a doctorate from the University of Kansas. |
| Sherry Pudloski |
Sherry Pudloski is currently the Chief Corporate Affairs Officer & Senior VP at Seagen Inc. Prior to this, she was the Executive VP-Corporate Affairs & Communications at Zoetis, Inc. from 2020 to 2021 and the Chief Communications Officer at Guardian Life Insurance Co. from 2017 to 2020. She completed her undergraduate degree at Duke University. |
| Chris Boshoff |
Chris Boshoff is currently the Chief Oncology Officer & Executive Vice President at Pfizer Inc. He is also the President at Seagen Inc. Additionally, he holds the position of Vice President-Translational Oncology at Pfizer (La Jolla). Previously, he served as a Non-Executive Director at Advanced Oncotherapy Plc in 2013. Dr. Boshoff obtained a doctorate degree from the University of Pretoria. |
